Cargando…

Intravascular optical imaging of high-risk plaques in vivo by targeting macrophage mannose receptors

Macrophages mediate atheroma expansion and disruption, and denote high-risk arterial plaques. Therefore, they are substantially gaining importance as a diagnostic imaging target for the detection of rupture-prone plaques. Here, we developed an injectable near-infrared fluorescence (NIRF) probe by ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ji Bak, Park, Kyeongsoon, Ryu, Jiheun, Lee, Jae Joong, Lee, Min Woo, Cho, Han Saem, Nam, Hyeong Soo, Park, Ok Kyu, Song, Joon Woo, Kim, Tae Shik, Oh, Dong Joo, Gweon, DaeGab, Oh, Wang-Yuhl, Yoo, Hongki, Kim, Jin Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780083/
https://www.ncbi.nlm.nih.gov/pubmed/26948523
http://dx.doi.org/10.1038/srep22608
Descripción
Sumario:Macrophages mediate atheroma expansion and disruption, and denote high-risk arterial plaques. Therefore, they are substantially gaining importance as a diagnostic imaging target for the detection of rupture-prone plaques. Here, we developed an injectable near-infrared fluorescence (NIRF) probe by chemically conjugating thiolated glycol chitosan with cholesteryl chloroformate, NIRF dye (cyanine 5.5 or 7), and maleimide-polyethylene glycol-mannose as mannose receptor binding ligands to specifically target a subset of macrophages abundant in high-risk plaques. This probe showed high affinity to mannose receptors, low toxicity, and allowed the direct visualization of plaque macrophages in murine carotid atheroma. After the scale-up of the MMR-NIRF probe, the administration of the probe facilitated in vivo intravascular imaging of plaque inflammation in coronary-sized vessels of atheromatous rabbits using a custom-built dual-modal optical coherence tomography (OCT)-NIRF catheter-based imaging system. This novel imaging approach represents a potential imaging strategy enabling the identification of high-risk plaques in vivo and holds promise for future clinical implications.